S 18616

Drug Profile

S 18616

Alternative Names: S18616

Latest Information Update: 14 Apr 2010

Price : $50

At a glance

  • Originator Servier
  • Class Analgesics
  • Mechanism of Action Alpha adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 12 Jul 2002 A preclinical study has been added to the Pain Control pharmacodynamics section
  • 07 Feb 2001 A study has been added to the pharmacodynamics section
  • 07 Feb 2001 Preclinical development for Pain in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top